83 related articles for article (PubMed ID: 8086630)
1. A study of c-myc oncogene expression and amplification in colorectal cancer.
Wang J; Li L; Li S; Cui H; Shen G
Chin Med Sci J; 1994 Mar; 9(1):24-8. PubMed ID: 8086630
[TBL] [Abstract][Full Text] [Related]
2. Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.
Greco C; Alvino S; Buglioni S; Assisi D; Lapenta R; Grassi A; Stigliano V; Mottolese M; Casale V
Anticancer Res; 2001; 21(5):3185-92. PubMed ID: 11848471
[TBL] [Abstract][Full Text] [Related]
3. Nuclear oncogene amplification or rearrangement is not involved in human colorectal malignancies.
Dolcetti R; De Re V; Viel A; Pistello M; Tavian M; Boiocchi M
Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1321-8. PubMed ID: 3181252
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of the c-myc proto-oncogene in colorectal carcinoma.
Smith DR; Myint T; Goh HS
Br J Cancer; 1993 Aug; 68(2):407-13. PubMed ID: 8347498
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta1 in colonic neoplasia: a genetic molecular and immunohistochemical study.
Cardillo MR; Yap E
J Exp Clin Cancer Res; 1997 Sep; 16(3):281-8. PubMed ID: 9387902
[TBL] [Abstract][Full Text] [Related]
6. [Expression, amplification and rearrangement of c-myc gene in human thyroid carcinoma].
Yang Y
Zhonghua Yi Xue Za Zhi; 1991 Jun; 71(6):304-6, 22. PubMed ID: 1667490
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between malignancy of gastric cancer and c-myc DNA amplification or overexpression of c-myc protein].
Nakata B; Onoda N; Chung YS; Maeda K; Nishimura S; Yashiro M; Nitta A; Kubo T; Kato Y; Sowa M
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():176-9. PubMed ID: 7611785
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of cyclin D1 mRNA in colorectal carcinomas and relationship to clinicopathological features: an in situ hybridization analysis.
Kristt D; Turner I; Koren R; Ramadan E; Gal R
Pathol Oncol Res; 2000; 6(1):65-70. PubMed ID: 10749591
[TBL] [Abstract][Full Text] [Related]
9. [Molecular biological study on the overexpression of c-myc gene in uterine cervical carcinomas].
Tanimoto H; Nagai N; Fujimoto H; Ohta S; Ohama K
Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):566-70. PubMed ID: 1619315
[TBL] [Abstract][Full Text] [Related]
10. [The significance of p53 gene mutations and expressions in human colorectal tumors].
Qian H; Yu B; Zhou X
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):332-5. PubMed ID: 8697968
[TBL] [Abstract][Full Text] [Related]
11. C-myc amplification and cluster analysis in human gastric carcinoma.
Kozma L; Kiss I; Hajdú J; Szentkereszty Z; Szakáll S; Ember I
Anticancer Res; 2001; 21(1B):707-10. PubMed ID: 11299830
[TBL] [Abstract][Full Text] [Related]
12. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
Jenkins RB; Qian J; Lieber MM; Bostwick DG
Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
[TBL] [Abstract][Full Text] [Related]
13. [Significance of apoptosis status and apoptosis-associated antigen expression in human colorectal adenocarcinoma sequence].
Li L; Yan L; Wei Y; Liu Z; Wang Z; Lei S; Huang G
Hua Xi Yi Ke Da Xue Xue Bao; 1999 Jun; 30(2):185-7, 191. PubMed ID: 12212055
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas.
Campo E; de la Calle-Martin O; Miquel R; Palacin A; Romero M; Fabregat V; Vives J; Cardesa A; Yague J
Cancer Res; 1991 Aug; 51(16):4436-42. PubMed ID: 1868464
[TBL] [Abstract][Full Text] [Related]
15. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines.
Erisman MD; Scott JK; Watt RA; Astrin SM
Oncogene; 1988 Apr; 2(4):367-78. PubMed ID: 3283655
[TBL] [Abstract][Full Text] [Related]
16. Fish detected p53 deletion and N-MYC amplification in colorectal cancer.
Ozakyol A; Ozdemir M; Artan S
Hepatogastroenterology; 2006; 53(68):192-5. PubMed ID: 16608022
[TBL] [Abstract][Full Text] [Related]
17. c-myc Gene amplification in primary stomach cancer.
Koda T; Matsushima S; Sasaki A; Danjo Y; Kakinuma M
Jpn J Cancer Res; 1985 Jul; 76(7):551-4. PubMed ID: 2993214
[TBL] [Abstract][Full Text] [Related]
18. Correlation of C-myc and HER-2/neu amplification and expression with histopathologic variables in uterine corpus cancer.
Monk BJ; Chapman JA; Johnson GA; Brightman BK; Wilczynski SP; Schell MJ; Fan H
Am J Obstet Gynecol; 1994 Nov; 171(5):1193-8. PubMed ID: 7977518
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of p53 overexpression in human colonic tumors.
Darmon E; Cleary KR; Wargovich MJ
Cancer Detect Prev; 1994; 18(3):187-95. PubMed ID: 8076381
[TBL] [Abstract][Full Text] [Related]
20. Analysis of c-myc oncogene in human esophageal carcinoma: immunohistochemistry, in situ hybridization and northern and Southern blot studies.
Miyazaki S; Sasno H; Shiga K; Sawai T; Nishihira T; Okamoto H; Mori S
Anticancer Res; 1992; 12(5):1747-55. PubMed ID: 1444241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]